Loading…

Multi-targeted mechanisms underlying the endothelial protective effects of the diabetic-safe sweetener erythritol

Diabetes is characterized by hyperglycemia and development of vascular pathology. Endothelial cell dysfunction is a starting point for pathogenesis of vascular complications in diabetes. We previously showed the polyol erythritol to be a hydroxyl radical scavenger preventing endothelial cell dysfunc...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2013-06, Vol.8 (6), p.e65741
Main Authors: Boesten, Daniëlle M P H J, Berger, Alvin, de Cock, Peter, Dong, Hua, Hammock, Bruce D, den Hartog, Gertjan J M, Bast, Aalt
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c692t-daff9ba86ca5650c3634519fd8ed54365aa6cb39a14ebb418a6c1f261d0b7b13
cites cdi_FETCH-LOGICAL-c692t-daff9ba86ca5650c3634519fd8ed54365aa6cb39a14ebb418a6c1f261d0b7b13
container_end_page
container_issue 6
container_start_page e65741
container_title PloS one
container_volume 8
creator Boesten, Daniëlle M P H J
Berger, Alvin
de Cock, Peter
Dong, Hua
Hammock, Bruce D
den Hartog, Gertjan J M
Bast, Aalt
description Diabetes is characterized by hyperglycemia and development of vascular pathology. Endothelial cell dysfunction is a starting point for pathogenesis of vascular complications in diabetes. We previously showed the polyol erythritol to be a hydroxyl radical scavenger preventing endothelial cell dysfunction onset in diabetic rats. To unravel mechanisms, other than scavenging of radicals, by which erythritol mediates this protective effect, we evaluated effects of erythritol in endothelial cells exposed to normal (7 mM) and high glucose (30 mM) or diabetic stressors (e.g. SIN-1) using targeted and transcriptomic approaches. This study demonstrates that erythritol (i.e. under non-diabetic conditions) has minimal effects on endothelial cells. However, under hyperglycemic conditions erythritol protected endothelial cells against cell death induced by diabetic stressors (i.e. high glucose and peroxynitrite). Also a number of harmful effects caused by high glucose, e.g. increased nitric oxide release, are reversed. Additionally, total transcriptome analysis indicated that biological processes which are differentially regulated due to high glucose are corrected by erythritol. We conclude that erythritol protects endothelial cells during high glucose conditions via effects on multiple targets. Overall, these data indicate a therapeutically important endothelial protective effect of erythritol under hyperglycemic conditions.
doi_str_mv 10.1371/journal.pone.0065741
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1365182685</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A478417250</galeid><doaj_id>oai_doaj_org_article_f8f852351a1e4f829913b185859d91ea</doaj_id><sourcerecordid>A478417250</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-daff9ba86ca5650c3634519fd8ed54365aa6cb39a14ebb418a6c1f261d0b7b13</originalsourceid><addsrcrecordid>eNqNkl9r1TAYxosobk6_gWhBELzosWmaNL0ZjOGfA5OBDm9DmrxpM3KasySdnm9vttONU1CQXCR583ueJC9Plr1G5QrhBn28dpMfhV1t3QirsqSkqdGT7Bi1uCpoVeKnB-uj7EUI12VJMKP0eXZU4YaQqqHH2c23yUZTROF7iKDyDchBjCZsQj6NCrzdmbHP4wA5jMql2Rph8613EWQ0t6msdVqF3Ol7ShnRQTSyCEJDHn5Bch3B5-B3cfAmOvsye6aFDfBqnk-yq8-frs6_FheXX9bnZxeFpG0VCyW0bjvBqBSEklJiimuCWq0YKFJjSoSgssOtQDV0XY1Y2iJdUaTKrukQPsne7m231gU-NytwlJSIVZSRRKz3hHLimm-92Qi_404Yfl9wvufCp69Y4JppRipMkEBQa1a1LcIdYoSRVrUIRPI6nW-bug0oCWP0wi5MlyejGXjvbjmmDW6rOhm8mw28u5kgxH88eaZ6kV5lRu2SmdyYIPlZ3bAaNRUpE7X6C5WGgo2RKS7apPpC8GEhSEyE37EXUwh8_eP7_7OXP5fs-wN2AGHjEJydonFjWIL1HpTeheBBP3YOlfwu7Q_d4Hdp53Pak-zNYdcfRQ_xxn8Adhj8rA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1365182685</pqid></control><display><type>article</type><title>Multi-targeted mechanisms underlying the endothelial protective effects of the diabetic-safe sweetener erythritol</title><source>PubMed (Medline)</source><source>ProQuest - Publicly Available Content Database</source><creator>Boesten, Daniëlle M P H J ; Berger, Alvin ; de Cock, Peter ; Dong, Hua ; Hammock, Bruce D ; den Hartog, Gertjan J M ; Bast, Aalt</creator><contributor>Johnson, Rajasingh</contributor><creatorcontrib>Boesten, Daniëlle M P H J ; Berger, Alvin ; de Cock, Peter ; Dong, Hua ; Hammock, Bruce D ; den Hartog, Gertjan J M ; Bast, Aalt ; Johnson, Rajasingh</creatorcontrib><description>Diabetes is characterized by hyperglycemia and development of vascular pathology. Endothelial cell dysfunction is a starting point for pathogenesis of vascular complications in diabetes. We previously showed the polyol erythritol to be a hydroxyl radical scavenger preventing endothelial cell dysfunction onset in diabetic rats. To unravel mechanisms, other than scavenging of radicals, by which erythritol mediates this protective effect, we evaluated effects of erythritol in endothelial cells exposed to normal (7 mM) and high glucose (30 mM) or diabetic stressors (e.g. SIN-1) using targeted and transcriptomic approaches. This study demonstrates that erythritol (i.e. under non-diabetic conditions) has minimal effects on endothelial cells. However, under hyperglycemic conditions erythritol protected endothelial cells against cell death induced by diabetic stressors (i.e. high glucose and peroxynitrite). Also a number of harmful effects caused by high glucose, e.g. increased nitric oxide release, are reversed. Additionally, total transcriptome analysis indicated that biological processes which are differentially regulated due to high glucose are corrected by erythritol. We conclude that erythritol protects endothelial cells during high glucose conditions via effects on multiple targets. Overall, these data indicate a therapeutically important endothelial protective effect of erythritol under hyperglycemic conditions.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0065741</identifier><identifier>PMID: 23755276</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acids ; Analysis ; Biological activity ; Biology ; Cell death ; Cell Death - drug effects ; Cell Survival - drug effects ; Cells, Cultured ; Complications ; Cytoprotection ; Deoxyguanosine - analogs &amp; derivatives ; Deoxyguanosine - metabolism ; Diabetes ; Diabetes mellitus ; Drug Evaluation, Preclinical ; Eicosanoids - metabolism ; Endothelial cells ; Endothelium ; Erythritol ; Erythritol - pharmacology ; Gene expression ; Glucose ; Glucose - pharmacology ; Glucose - physiology ; Human Umbilical Vein Endothelial Cells - drug effects ; Human Umbilical Vein Endothelial Cells - physiology ; Humans ; Hydroxyl radicals ; Hyperglycemia ; Hyperglycemia - metabolism ; Kinases ; Medicine ; Natural language processing ; Nitric oxide ; Oxidative Stress ; Pathogenesis ; Penicillin ; Peroxynitrite ; Polyols ; Proteins ; Rats ; Rodents ; Sweetening Agents - pharmacology ; Toxicology ; Transcriptome - drug effects</subject><ispartof>PloS one, 2013-06, Vol.8 (6), p.e65741</ispartof><rights>COPYRIGHT 2013 Public Library of Science</rights><rights>2013 Boesten et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2013 Boesten et al 2013 Boesten et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-daff9ba86ca5650c3634519fd8ed54365aa6cb39a14ebb418a6c1f261d0b7b13</citedby><cites>FETCH-LOGICAL-c692t-daff9ba86ca5650c3634519fd8ed54365aa6cb39a14ebb418a6c1f261d0b7b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1365182685/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1365182685?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23755276$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Johnson, Rajasingh</contributor><creatorcontrib>Boesten, Daniëlle M P H J</creatorcontrib><creatorcontrib>Berger, Alvin</creatorcontrib><creatorcontrib>de Cock, Peter</creatorcontrib><creatorcontrib>Dong, Hua</creatorcontrib><creatorcontrib>Hammock, Bruce D</creatorcontrib><creatorcontrib>den Hartog, Gertjan J M</creatorcontrib><creatorcontrib>Bast, Aalt</creatorcontrib><title>Multi-targeted mechanisms underlying the endothelial protective effects of the diabetic-safe sweetener erythritol</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Diabetes is characterized by hyperglycemia and development of vascular pathology. Endothelial cell dysfunction is a starting point for pathogenesis of vascular complications in diabetes. We previously showed the polyol erythritol to be a hydroxyl radical scavenger preventing endothelial cell dysfunction onset in diabetic rats. To unravel mechanisms, other than scavenging of radicals, by which erythritol mediates this protective effect, we evaluated effects of erythritol in endothelial cells exposed to normal (7 mM) and high glucose (30 mM) or diabetic stressors (e.g. SIN-1) using targeted and transcriptomic approaches. This study demonstrates that erythritol (i.e. under non-diabetic conditions) has minimal effects on endothelial cells. However, under hyperglycemic conditions erythritol protected endothelial cells against cell death induced by diabetic stressors (i.e. high glucose and peroxynitrite). Also a number of harmful effects caused by high glucose, e.g. increased nitric oxide release, are reversed. Additionally, total transcriptome analysis indicated that biological processes which are differentially regulated due to high glucose are corrected by erythritol. We conclude that erythritol protects endothelial cells during high glucose conditions via effects on multiple targets. Overall, these data indicate a therapeutically important endothelial protective effect of erythritol under hyperglycemic conditions.</description><subject>Acids</subject><subject>Analysis</subject><subject>Biological activity</subject><subject>Biology</subject><subject>Cell death</subject><subject>Cell Death - drug effects</subject><subject>Cell Survival - drug effects</subject><subject>Cells, Cultured</subject><subject>Complications</subject><subject>Cytoprotection</subject><subject>Deoxyguanosine - analogs &amp; derivatives</subject><subject>Deoxyguanosine - metabolism</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Drug Evaluation, Preclinical</subject><subject>Eicosanoids - metabolism</subject><subject>Endothelial cells</subject><subject>Endothelium</subject><subject>Erythritol</subject><subject>Erythritol - pharmacology</subject><subject>Gene expression</subject><subject>Glucose</subject><subject>Glucose - pharmacology</subject><subject>Glucose - physiology</subject><subject>Human Umbilical Vein Endothelial Cells - drug effects</subject><subject>Human Umbilical Vein Endothelial Cells - physiology</subject><subject>Humans</subject><subject>Hydroxyl radicals</subject><subject>Hyperglycemia</subject><subject>Hyperglycemia - metabolism</subject><subject>Kinases</subject><subject>Medicine</subject><subject>Natural language processing</subject><subject>Nitric oxide</subject><subject>Oxidative Stress</subject><subject>Pathogenesis</subject><subject>Penicillin</subject><subject>Peroxynitrite</subject><subject>Polyols</subject><subject>Proteins</subject><subject>Rats</subject><subject>Rodents</subject><subject>Sweetening Agents - pharmacology</subject><subject>Toxicology</subject><subject>Transcriptome - drug effects</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl9r1TAYxosobk6_gWhBELzosWmaNL0ZjOGfA5OBDm9DmrxpM3KasySdnm9vttONU1CQXCR583ueJC9Plr1G5QrhBn28dpMfhV1t3QirsqSkqdGT7Bi1uCpoVeKnB-uj7EUI12VJMKP0eXZU4YaQqqHH2c23yUZTROF7iKDyDchBjCZsQj6NCrzdmbHP4wA5jMql2Rph8613EWQ0t6msdVqF3Ol7ShnRQTSyCEJDHn5Bch3B5-B3cfAmOvsye6aFDfBqnk-yq8-frs6_FheXX9bnZxeFpG0VCyW0bjvBqBSEklJiimuCWq0YKFJjSoSgssOtQDV0XY1Y2iJdUaTKrukQPsne7m231gU-NytwlJSIVZSRRKz3hHLimm-92Qi_404Yfl9wvufCp69Y4JppRipMkEBQa1a1LcIdYoSRVrUIRPI6nW-bug0oCWP0wi5MlyejGXjvbjmmDW6rOhm8mw28u5kgxH88eaZ6kV5lRu2SmdyYIPlZ3bAaNRUpE7X6C5WGgo2RKS7apPpC8GEhSEyE37EXUwh8_eP7_7OXP5fs-wN2AGHjEJydonFjWIL1HpTeheBBP3YOlfwu7Q_d4Hdp53Pak-zNYdcfRQ_xxn8Adhj8rA</recordid><startdate>20130605</startdate><enddate>20130605</enddate><creator>Boesten, Daniëlle M P H J</creator><creator>Berger, Alvin</creator><creator>de Cock, Peter</creator><creator>Dong, Hua</creator><creator>Hammock, Bruce D</creator><creator>den Hartog, Gertjan J M</creator><creator>Bast, Aalt</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20130605</creationdate><title>Multi-targeted mechanisms underlying the endothelial protective effects of the diabetic-safe sweetener erythritol</title><author>Boesten, Daniëlle M P H J ; Berger, Alvin ; de Cock, Peter ; Dong, Hua ; Hammock, Bruce D ; den Hartog, Gertjan J M ; Bast, Aalt</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-daff9ba86ca5650c3634519fd8ed54365aa6cb39a14ebb418a6c1f261d0b7b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acids</topic><topic>Analysis</topic><topic>Biological activity</topic><topic>Biology</topic><topic>Cell death</topic><topic>Cell Death - drug effects</topic><topic>Cell Survival - drug effects</topic><topic>Cells, Cultured</topic><topic>Complications</topic><topic>Cytoprotection</topic><topic>Deoxyguanosine - analogs &amp; derivatives</topic><topic>Deoxyguanosine - metabolism</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Drug Evaluation, Preclinical</topic><topic>Eicosanoids - metabolism</topic><topic>Endothelial cells</topic><topic>Endothelium</topic><topic>Erythritol</topic><topic>Erythritol - pharmacology</topic><topic>Gene expression</topic><topic>Glucose</topic><topic>Glucose - pharmacology</topic><topic>Glucose - physiology</topic><topic>Human Umbilical Vein Endothelial Cells - drug effects</topic><topic>Human Umbilical Vein Endothelial Cells - physiology</topic><topic>Humans</topic><topic>Hydroxyl radicals</topic><topic>Hyperglycemia</topic><topic>Hyperglycemia - metabolism</topic><topic>Kinases</topic><topic>Medicine</topic><topic>Natural language processing</topic><topic>Nitric oxide</topic><topic>Oxidative Stress</topic><topic>Pathogenesis</topic><topic>Penicillin</topic><topic>Peroxynitrite</topic><topic>Polyols</topic><topic>Proteins</topic><topic>Rats</topic><topic>Rodents</topic><topic>Sweetening Agents - pharmacology</topic><topic>Toxicology</topic><topic>Transcriptome - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boesten, Daniëlle M P H J</creatorcontrib><creatorcontrib>Berger, Alvin</creatorcontrib><creatorcontrib>de Cock, Peter</creatorcontrib><creatorcontrib>Dong, Hua</creatorcontrib><creatorcontrib>Hammock, Bruce D</creatorcontrib><creatorcontrib>den Hartog, Gertjan J M</creatorcontrib><creatorcontrib>Bast, Aalt</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing and Allied Health Source</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boesten, Daniëlle M P H J</au><au>Berger, Alvin</au><au>de Cock, Peter</au><au>Dong, Hua</au><au>Hammock, Bruce D</au><au>den Hartog, Gertjan J M</au><au>Bast, Aalt</au><au>Johnson, Rajasingh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multi-targeted mechanisms underlying the endothelial protective effects of the diabetic-safe sweetener erythritol</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2013-06-05</date><risdate>2013</risdate><volume>8</volume><issue>6</issue><spage>e65741</spage><pages>e65741-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Diabetes is characterized by hyperglycemia and development of vascular pathology. Endothelial cell dysfunction is a starting point for pathogenesis of vascular complications in diabetes. We previously showed the polyol erythritol to be a hydroxyl radical scavenger preventing endothelial cell dysfunction onset in diabetic rats. To unravel mechanisms, other than scavenging of radicals, by which erythritol mediates this protective effect, we evaluated effects of erythritol in endothelial cells exposed to normal (7 mM) and high glucose (30 mM) or diabetic stressors (e.g. SIN-1) using targeted and transcriptomic approaches. This study demonstrates that erythritol (i.e. under non-diabetic conditions) has minimal effects on endothelial cells. However, under hyperglycemic conditions erythritol protected endothelial cells against cell death induced by diabetic stressors (i.e. high glucose and peroxynitrite). Also a number of harmful effects caused by high glucose, e.g. increased nitric oxide release, are reversed. Additionally, total transcriptome analysis indicated that biological processes which are differentially regulated due to high glucose are corrected by erythritol. We conclude that erythritol protects endothelial cells during high glucose conditions via effects on multiple targets. Overall, these data indicate a therapeutically important endothelial protective effect of erythritol under hyperglycemic conditions.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>23755276</pmid><doi>10.1371/journal.pone.0065741</doi><tpages>e65741</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2013-06, Vol.8 (6), p.e65741
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1365182685
source PubMed (Medline); ProQuest - Publicly Available Content Database
subjects Acids
Analysis
Biological activity
Biology
Cell death
Cell Death - drug effects
Cell Survival - drug effects
Cells, Cultured
Complications
Cytoprotection
Deoxyguanosine - analogs & derivatives
Deoxyguanosine - metabolism
Diabetes
Diabetes mellitus
Drug Evaluation, Preclinical
Eicosanoids - metabolism
Endothelial cells
Endothelium
Erythritol
Erythritol - pharmacology
Gene expression
Glucose
Glucose - pharmacology
Glucose - physiology
Human Umbilical Vein Endothelial Cells - drug effects
Human Umbilical Vein Endothelial Cells - physiology
Humans
Hydroxyl radicals
Hyperglycemia
Hyperglycemia - metabolism
Kinases
Medicine
Natural language processing
Nitric oxide
Oxidative Stress
Pathogenesis
Penicillin
Peroxynitrite
Polyols
Proteins
Rats
Rodents
Sweetening Agents - pharmacology
Toxicology
Transcriptome - drug effects
title Multi-targeted mechanisms underlying the endothelial protective effects of the diabetic-safe sweetener erythritol
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A35%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multi-targeted%20mechanisms%20underlying%20the%20endothelial%20protective%20effects%20of%20the%20diabetic-safe%20sweetener%20erythritol&rft.jtitle=PloS%20one&rft.au=Boesten,%20Dani%C3%ABlle%20M%20P%20H%20J&rft.date=2013-06-05&rft.volume=8&rft.issue=6&rft.spage=e65741&rft.pages=e65741-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0065741&rft_dat=%3Cgale_plos_%3EA478417250%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c692t-daff9ba86ca5650c3634519fd8ed54365aa6cb39a14ebb418a6c1f261d0b7b13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1365182685&rft_id=info:pmid/23755276&rft_galeid=A478417250&rfr_iscdi=true